About DEBx Medical
DEBx Medical is a company based in Rotterdam (Netherlands) founded in 2019 by Alberto Cogo, Carlo Bignozzi, and Bert Quint.. DEBx Medical has raised $10.81 million across 2 funding rounds from investors including TVM Capital Life Science and TVM Capital Healthcare. DEBx Medical offers products and services including DEBRICHEM. DEBx Medical operates in a competitive market with competitors including Ilya Pharma, QBiotics, MediWound, Resolution Therapeutics and SanuWave, among others.
- Headquarter Rotterdam, Netherlands
- Founders Alberto Cogo, Carlo Bignozzi, Bert Quint
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10.81 M (USD)
in 2 rounds
-
Latest Funding Round
-
Investors
TVM Capital Life Science
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DEBx Medical
DEBx Medical offers a comprehensive portfolio of products and services, including DEBRICHEM. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Eliminates biofilm and infection in hard-to-heal wounds via quick application.
Funding Insights of DEBx Medical
DEBx Medical has successfully raised a total of $10.81M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Last Round
-
First Round
First Round
(22 May 2023)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2024 | Amount | Private Equity Round - DEBx Medical | Valuation | TVM |
|
| May, 2023 | Amount | Series B - DEBx Medical | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in DEBx Medical
DEBx Medical has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include TVM Capital Life Science and TVM Capital Healthcare. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Capital is invested in life science innovations for healthcare transformation.
|
Founded Year | Domain | Location | |
|
Healthcare growth capital investments are made in transformational companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by DEBx Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - DEBx Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Debx Medical Comparisons
Competitors of DEBx Medical
DEBx Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ilya Pharma, QBiotics, MediWound, Resolution Therapeutics and SanuWave, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biological drugs for skin and mucosa wound treatment are developed.
|
|
| domain | founded_year | HQ Location |
Small molecules from plant extracts are developed for medical applications.
|
|
| domain | founded_year | HQ Location |
Enzymatic therapies for tissue repair and regeneration are developed.
|
|
| domain | founded_year | HQ Location |
Macrophage cell therapies are developed for inflammatory and liver diseases.
|
|
| domain | founded_year | HQ Location |
Noninvasive devices and biologics for wound healing are developed.
|
|
| domain | founded_year | HQ Location |
Regenerative biomaterials for wounds are developed using particle technology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Debx Medical
Frequently Asked Questions about DEBx Medical
When was DEBx Medical founded?
DEBx Medical was founded in 2019 and raised its 1st funding round 4 years after it was founded.
Where is DEBx Medical located?
DEBx Medical is headquartered in Rotterdam, Netherlands. It is registered at Rotterdam, South Holland, Netherlands.
Who is the current CEO of DEBx Medical?
Bert Quint is the current CEO of DEBx Medical. They have also founded this company.
Is DEBx Medical a funded company?
DEBx Medical is a funded company, having raised a total of $10.81M across 2 funding rounds to date. The company's 1st funding round was a Series B of $10.81M, raised on May 22, 2023.
What does DEBx Medical do?
Founded in 2019 in Rotterdam, Netherlands, DEBx Medical operates in the medical sector focused on chronic wound care. Products are developed to target biofilms and infections through an application process adapted for diverse healthcare settings. Infected tissue removal is facilitated, aiding wound bed preparation. Treatment experiences for patients and providers are supported without altering core clinical workflows.
Who are the top competitors of DEBx Medical?
DEBx Medical's top competitors include Ilya Pharma, SanuWave and QBiotics.
What products or services does DEBx Medical offer?
DEBx Medical offers DEBRICHEM.
Who are DEBx Medical's investors?
DEBx Medical has 2 investors. Key investors include TVM Capital Life Science, and TVM Capital Healthcare.